The Robotic Surgeon Blog
-
Dr. Menon at EAU meeting
UroToday – EAU 2007 – AUA Lecture at the EAU 2007 – “The Role of Robotics in Urology” The market is primarily coming from patient “advertising” to other patients by word of mouth and use of the internet. The perceived benefit is likely based upon decreased blood loss and quicker recovery. He hypothesized that this…
-
Robotic Prostatectomy Results from Vattikuti Institute
UroToday – European Urology – Vattikuti Institute Prostatectomy: Contemporary Technique and Analysis of Results Results Complete follow-up information was obtained in 1142 patients with a minimum follow-up of 12 mo (range: 12–66 mo; median: 36 mo). The actuarial 5-yr biochemical recurrence rate was 8.4% and the actual biochemical recurrence rate was 2.3%. Median duration of…
-
Robotic Surgery Growth: Cardiac surgery started in the Czech Republic
First heart surgery performed by robots in CzechRep – Prague Daily Monitor First heart surgery performed by robots in CzechRep By Prague Daily Monitor/ČTK / Published 16 March 2007 Prague, March 15 (CTK) – The first robotic heart operation was performed in the Czech Republic in Prague’s Na Homolce hospital this week, hospital spokeswoman Jitka…
-
Robotic Prostatectomy Review
Robotic Assisted Laparoscopic Radical Prostatectomy Conclusion Our review of the data for RALP shows a promising procedure in evolution. The limitations of robotic technology such as lack of haptic feedback seem to be outweighed by the advantages of improved visualisation and miniature instrumentation. While economic considerations are paramount the procedure is continuing to grow because…
-
Prostate cancer surgery: hospital stays for open vs robotic surgery
Length of Hospital Stay Similar for Robotic Assisted and Conventional Prostatectomy The current study prospectively compared length of hospital stay in 374 patients who underwent conventional RP and 629 who underwent LRP between 2002 and 2005. These authors reported that 94.3% of patients undergoing RP and 97.5% undergoing LRP were discharged on or before postoperative…
-
Prostate Biopsy: Side Effects and Risks
UroToday – EAU 2007 – Session on Prostate Biopsy 1 The 7,074 biopsies were performed in 5,153 men. Minor complications included hematuria >1 day (13.8%), hematospermia (35.8%), and rectal bleeding (2.1%). Major complications were prostatitis, epididymitis, fever >38C, rectal bleeding >2 days, and urinary retention, all <1.0%. This study validates the safety of TRUS biopsy…
-
HIFU and cryosurgery for prostate cancer
UroToday – EAU 2007 – Minimally Invasive and Other Treatment Strategies in Localized Prostate Cancer The authors conclude that this treatment modality is appropriate for patients with localized CaP who are not candidates for surgery. The oncological outcomes appear inferior to rates reported for radiotherapy and surgery. 2 abstracts were summarized from the EAU’s meeting:…
-
Testosterone replacement after seeds for prostate cancer
Testosterone Replacement May Be Safe After Prostate Cancer NEW YORK (Reuters Health) Mar 23 – Testosterone replacement therapy (TRT) appears safe for men who experience hypogonadal symptoms after brachytherapy for prostate cancer. “Men who have undergone potentially curative treatment for prostate cancer but also suffer from severe effects of hypogonadism may benefit from a trial…
-
Prostate Cancer: Surgery for locally advanced prostate cancer
Prostatectomy Effective for SV-Negative Locally Advanced Prostate Cancer At a mean follow-up of 37.2 months (median, 21.2 months), the pT3 (pT3a plus pT3b) patients’ overall and disease-specific 10-year survival rates were 77% and 92%, respectively, and at 15 years, 52% and 75%. These results are similar to those of previous studies for overall survival of…